Stay updated with breaking news from Mitchc Hill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inari Medical (NASDAQ:NARI – Free Report) had its price objective decreased by Piper Sandler from $55.00 to $50.00 in a research note published on Wednesday, Benzinga reports. Piper Sandler currently has a neutral rating on the stock. Several other equities research analysts also recently commented on NARI. Needham & Company LLC decreased their price objective […]
Inari Medical (NASDAQ:NARI – Free Report) had its price objective trimmed by Needham & Company LLC from $72.00 to $57.00 in a research note released on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts also recently commented on NARI. Truist Financial decreased their target price on shares […]
Inari Medical (NASDAQ:NARI – Free Report) had its price objective cut by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. NARI has been the topic of a number of other reports. Piper Sandler downgraded shares of Inari […]
Inari Medical (NASDAQ:NARI – Free Report) had its price target lowered by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. NARI has been the subject of several other research reports. Piper Sandler lowered Inari Medical […]
Inari Medical (NASDAQ:NARI – Free Report) had its target price lowered by Wells Fargo & Company from $100.00 to $84.00 in a report released on Wednesday morning, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Several other analysts have also commented on the stock. Canaccord Genuity Group reaffirmed a […]